KTTA

$0.00

(

0.00%

)
Quote details

stock

Pasithea Therapeutics Corp

NASDAQ | KTTA

0.72

USD

$0.00

(

0.00%

)

At Close (As of Oct 14, 2025)

$5.57M

Market Cap

-

P/E Ratio

-7.13

EPS

$4.57

52 Week High

$0.65

52 Week Low

HEALTHCARE

Sector

KTTA Chart

Recent Chart
Price Action

KTTA Technicals

Tags:

KTTA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$649K
Total Revenue $0
Cost Of Revenue $649K
Costof Goods And Services Sold $649K
Operating Income -$14M
Selling General And Administrative $7.1M
Research And Development $7.2M
Operating Expenses $14M
Investment Income Net -
Net Interest Income $423K
Interest Income $423K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $649K
Income Before Tax -$14M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$14M
Comprehensive Income Net Of Tax -
Ebit -$14M
Ebitda -$13M
Net Income -$14M

Revenue & Profitability

Earnings Performance

KTTA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $16M
Total Current Assets $7.4M
Cash And Cash Equivalents At Carrying Value $6.9M
Cash And Short Term Investments $6.9M
Inventory -
Current Net Receivables -
Total Non Current Assets $8.7M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $7.3M
Intangible Assets Excluding Goodwill $7.3M
Goodwill $1.3M
Investments -
Long Term Investments -
Short Term Investments $6.9B
Other Current Assets $446K
Other Non Current Assets -
Total Liabilities $1.3M
Total Current Liabilities $1.1M
Current Accounts Payable $1.1M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $162K
Capital Lease Obligations $0
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $1.1M
Other Non Current Liabilities -
Total Shareholder Equity $15M
Treasury Stock -
Retained Earnings -$50B
Common Stock $139
Common Stock Shares Outstanding $1.1M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$14K
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $649
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $4.5B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $360M
Dividend Payout Common Stock $360M
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$14K

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$649K
Total Revenue $0
Cost Of Revenue $649K
Costof Goods And Services Sold $649K
Operating Income -$14M
Selling General And Administrative $7.1M
Research And Development $7.2M
Operating Expenses $14M
Investment Income Net -
Net Interest Income $423K
Interest Income $423K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $649K
Income Before Tax -$14M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$14M
Comprehensive Income Net Of Tax -
Ebit -$14M
Ebitda -$13M
Net Income -$14M

KTTA News

KTTA Profile

Pasithea Therapeutics Corp Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Pasithea Therapeutics Corp. is a Miami Beach, Florida-based biopharmaceutical company dedicated to the development of novel therapeutics for psychiatric and neurological disorders. The firm focuses on innovative treatment approaches utilizing psychedelic compounds, aiming to address significant unmet medical needs and enhance patient outcomes. With a strong emphasis on scientific research and clinical development, Pasithea is strategically positioned to contribute to the evolving landscape of mental health therapies. The company's commitment to advancing its proprietary platform reflects its potential for long-term growth and value creation within the healthcare sector.

VHAI
+66.66%
$0.00
YYAI
-12.35%
$0.14
UGRO
+54.52%
$0.57
BURU
-20.87%
$0.40
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
TMQ
+59.90%
$10.49
NVTS
+30.74%
$13.03
RGTI
+2.22%
$56.13
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
RR
+4.34%
$6.73
JOBY
+7.30%
$17.99
SSKN
+43.83%
$2.21
INTC
-3.77%
$35.81
ITP
+31.05%
$0.34
RXRX
+8.22%
$5.98
F
+1.08%
$11.66
EDHL
+92.12%
$0.95
CRML
+28.00%
$29.80
NAK
+4.13%
$2.76
DVLT
+24.76%
$2.12
ACHR
+2.37%
$13.07
TSLA
-1.52%
$429.24
WULF
+9.43%
$15.32
IONZ
+10.43%
$2.54
AXDX
-61.36%
$0.03
TLRY
-5.02%
$1.60
GPUS
-6.93%
$0.40
SOUN
+8.73%
$20.81
MNTS
+22.37%
$1.75
MARA
+10.25%
$22.31
BBD
+2.06%
$3.15
ETHD
+6.45%
$3.54
CIFR
+2.70%
$20.89
AMD
+3.10%
$223.14
UUUU
+10.30%
$26.22
SOFI
+2.22%
$27.74
QBTS
+10.06%
$44.71
NIO
-5.15%
$6.81
ERIC
+20.62%
$9.85
BTBT
+6.38%
$4.00
AAL
+4.04%
$12.21
CLF
+2.13%
$14.12
NOK
+4.28%
$5.47
UAMY
+7.06%
$17.89
IREN
+8.16%
$69.37
AREC
+28.21%
$6.38
BTG
+0.94%
$5.36
ADAP
-11.21%
$0.15
KDLY
-1.56%
$0.85
RIG
+3.89%
$3.20
PLTR
+1.29%
$179.50
APLD
+2.87%
$35.22
USAR
-2.72%
$37.62
JDZG
+55.32%
$2.92
CLSK
+11.89%
$22.42
EOSE
+23.37%
$17.05
QS
-0.76%
$16.86
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
ASST
-5.60%
$1.01
ABAT
+17.00%
$10.78
RMBL
+60.50%
$3.21
RF
+2.84%
$25.25
MP
+3.78%
$98.66
QUBT
+7.43%
$23.05
AMZN
-1.69%
$216.34
ADD
-25.47%
$0.05
T
+2.12%
$26.13
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
SRM
+53.27%
$10.30
HPE
+0.76%
$24.99
BCRX
-8.59%
$6.43
AQMS
+198.89%
$29.62
PFE
-0.89%
$24.50
BAC
+2.37%
$50.02
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
VALE
+2.41%
$11.01
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NB
+3.09%
$11.67
SLB
+1.73%
$32.27
NAKA
-6.57%
$0.80
DFLI
-2.50%
$1.53
WLGS
-5.57%
$0.04
WFC
+7.46%
$84.81
WWR
+29.29%
$2.56
ABEV
+0.93%
$2.16
ETWO
0.00%
$3.30
BULL
-0.59%
$11.67
GDXD
+3.93%
$0.76
RIOT
+2.25%
$22.19
VHAI
+66.66%
$0.00
YYAI
-12.35%
$0.14
UGRO
+54.52%
$0.57
BURU
-20.87%
$0.40
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
TMQ
+59.90%
$10.49
NVTS
+30.74%
$13.03
RGTI
+2.22%
$56.13
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
RR
+4.34%
$6.73
JOBY
+7.30%
$17.99
SSKN
+43.83%
$2.21
INTC
-3.77%
$35.81
ITP
+31.05%
$0.34
RXRX
+8.22%
$5.98
F
+1.08%
$11.66
EDHL
+92.12%
$0.95
CRML
+28.00%
$29.80
NAK
+4.13%
$2.76
DVLT
+24.76%
$2.12
ACHR
+2.37%
$13.07
TSLA
-1.52%
$429.24
WULF
+9.43%
$15.32
IONZ
+10.43%
$2.54
AXDX
-61.36%
$0.03
TLRY
-5.02%
$1.60
GPUS
-6.93%
$0.40
SOUN
+8.73%
$20.81
MNTS
+22.37%
$1.75
MARA
+10.25%
$22.31
BBD
+2.06%
$3.15
ETHD
+6.45%
$3.54
CIFR
+2.70%
$20.89
AMD
+3.10%
$223.14
UUUU
+10.30%
$26.22
SOFI
+2.22%
$27.74
QBTS
+10.06%
$44.71
NIO
-5.15%
$6.81
ERIC
+20.62%
$9.85
BTBT
+6.38%
$4.00
AAL
+4.04%
$12.21
CLF
+2.13%
$14.12
NOK
+4.28%
$5.47
UAMY
+7.06%
$17.89
IREN
+8.16%
$69.37
AREC
+28.21%
$6.38
BTG
+0.94%
$5.36
ADAP
-11.21%
$0.15
KDLY
-1.56%
$0.85
RIG
+3.89%
$3.20
PLTR
+1.29%
$179.50
APLD
+2.87%
$35.22
USAR
-2.72%
$37.62
JDZG
+55.32%
$2.92
CLSK
+11.89%
$22.42
EOSE
+23.37%
$17.05
QS
-0.76%
$16.86
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
ASST
-5.60%
$1.01
ABAT
+17.00%
$10.78
RMBL
+60.50%
$3.21
RF
+2.84%
$25.25
MP
+3.78%
$98.66
QUBT
+7.43%
$23.05
AMZN
-1.69%
$216.34
ADD
-25.47%
$0.05
T
+2.12%
$26.13
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
SRM
+53.27%
$10.30
HPE
+0.76%
$24.99
BCRX
-8.59%
$6.43
AQMS
+198.89%
$29.62
PFE
-0.89%
$24.50
BAC
+2.37%
$50.02
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
VALE
+2.41%
$11.01
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NB
+3.09%
$11.67
SLB
+1.73%
$32.27
NAKA
-6.57%
$0.80
DFLI
-2.50%
$1.53
WLGS
-5.57%
$0.04
WFC
+7.46%
$84.81
WWR
+29.29%
$2.56
ABEV
+0.93%
$2.16
ETWO
0.00%
$3.30
BULL
-0.59%
$11.67
GDXD
+3.93%
$0.76
RIOT
+2.25%
$22.19

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.